Understanding Ketamine's Dissociative Effects (KD Study)
Recruiting · NCT04861051 · Interventional (participants receive a specific treatment) · Lead sponsor: Stanford University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 1
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patient in Stanford Epilepsy Monitoring Unit
- Age \>18 years old.
Exclusion criteria
- Lifetime psychotic or bipolar disorder
- Inability to speak, read or understand English
- Pregnant or nursing females
- Prior adverse ketamine response
Where it is running
1 location listed across 1 US state.
- Stanford University School of Medicine - Palo Alto, California, United States